Trimethoxysilane

We are Trimethoxysilane CAS:2487-90-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Trimethoxysilane
CAS.NO:2487-90-3
Synonyms:Silane,trimethoxy; trimethoxy silane; trimethoxylsiloxane; 
TriMethoxysilane; Silane, trimethoxy-;
Molecular Formula:C3H10O3Si
Molecular Weight:122.19500
 
Physical and Chemical Properties:
Density:0.96;
Melting point:-115oC;
Boiling point:81oC;
Flash point:-9oC;
Index of Refraction:1.358;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥99.0%
 
Packing:170 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used as an intermediate for other functional organosilanes.

Trimethoxysilane


Related News: Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.(2S,3aR,7aS)-2,3,3a,4,5,6,7,7a-octahydro-1H-indole-2-carboxylic acid,hydrochloride CAS:144540-75-0 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.N-(2-Hydroxyethyl)piperazine In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.188612-53-5 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.

Related Products
Product Name
1,3-BIS(ISOCYANATOMETHYL)CYCLOHEXANE View Details
methyl 3-(2-methoxy-5-methylphenyl)-3-phenylpropanoate View Details
Lubiprostone Cas:136790-76-6 View Details
n-ethylaniline Cas:103-69-5 manufacturer 4-Bromofluorobenzene Cas:460-00-4 manufacturer BENZYLTRIMETHYLAMMONIUM CHLORIDE Cas:56-93-9 manufacturer 4-Bromo-2-fluoro-1-(trifluoromethoxy)benzene manufacturer 1-Cyclopropylnaphthalene Cas:25033-19-6 manufacturer